Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron

A Corrigendum to this article was published on 01 August 2006

This article has been updated

Abstract

Neurodegenerative disorders with high brain iron include Parkinson disease, Alzheimer disease and several childhood genetic disorders categorized as neuroaxonal dystrophies. We mapped a locus for infantile neuroaxonal dystrophy (INAD) and neurodegeneration with brain iron accumulation (NBIA) to chromosome 22q12-q13 and identified mutations in PLA2G6, encoding a calcium-independent group VI phospholipase A2, in NBIA, INAD and the related Karak syndrome. This discovery implicates phospholipases in the pathogenesis of neurodegenerative disorders with iron dyshomeostasis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Schematic showing iPLA2-VIA protein structure7 and mutation-derived changes.

Similar content being viewed by others

Change history

  • 17 July 2006

    In the version of this article initially published, the authors neglected to acknowledge sample contributions. Samples were obtained from the "Cell line and DNA bank from patients affected by genetic diseases" collection at the Giannina Gaslini Institute (http://www.gaslini.org/labdppm.htm) supported by Italian Telethon grants (project #GTF04002). This error has been corrected in the PDF version of the article.

References

  1. Nardocci, N. et al. Neurology 52, 1472–1478 (1999).

    Article  CAS  Google Scholar 

  2. Hayflick, S.J. et al. N. Engl. J. Med. 348, 33–40 (2003).

    Article  CAS  Google Scholar 

  3. Zhou, B. et al. Nat. Genet. 28, 345–349 (2001).

    Article  CAS  Google Scholar 

  4. Mubaidin, A. et al. J. Med. Genet. 40, 543–546 (2003).

    Article  CAS  Google Scholar 

  5. Farina, L. et al. Neuroradiology 41, 376–380 (1999).

    Article  CAS  Google Scholar 

  6. Simonati, A., Trevisan, C., Salviati, A. & Rizzuto, N. Neuropediatrics 30, 151–154 (1999).

    Article  CAS  Google Scholar 

  7. Balsinde, J. & Balboa, M.A. Cell. Signal. 17, 1052–1062 (2005).

    Article  CAS  Google Scholar 

  8. Larsson, P.K., Claesson, H.E. & Kennedy, B.P. J. Biol. Chem. 273, 207–214 (1998).

    Article  CAS  Google Scholar 

  9. Baburina, I. & Jackowski, S. J. Biol. Chem. 274, 9400–9408 (1999).

    Article  CAS  Google Scholar 

  10. Farooqui, A.A., Ong, W.Y. & Horrocks, L.A. Neurochem. Res. 29, 1961–1977 (2004).

    Article  CAS  Google Scholar 

  11. Zecca, L., Youdim, M.B., Riederer, P., Connor, J.R. & Crichton, R.R. Nat. Rev. Neurosci. 5, 863–873 (2004).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to the many contributing individuals, families and physicians. This work was funded by the Wellcome Trust and WellChild (E.M.), by the US National Eye Institute, L'Association Internationale De Dystrophie Neuro Axonale Infantile, the US National Institute of Child Health and Human Development, and the R.J. Murdock Foundation (S.J.H.) and by the NBIA Disorders Association and NORD (E.M., S.J.H.). Additional support was provided by the Paolo Zorzi Foundation, the Italian National Ministry of Health and the Oregon Alzheimer Disease Center Grant (P30 AG008017). Genotyping services were provided by the CIDR through a federal contract from the US NIH to The Johns Hopkins University, contract number N01-HG-65403 and by the OHSU GCRC (grant M01 RR000334). We thank H. Consencgo for technical assistance. J.G. is an investigator with the Howard Hughes Medical Institute.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susan J Hayflick.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

Pedigree and genotypes of NBIA index family. (PDF 101 kb)

Supplementary Fig. 2

INAD1 locus candidate region. (PDF 142 kb)

Supplementary Fig. 3

PLA2G6 genomic organization and index patient mutations. (PDF 85 kb)

Supplementary Fig. 4

Brain MRI of individual with NBIA. (PDF 92 kb)

Supplementary Table 1

Primer sequences. (PDF 62 kb)

Supplementary Methods (PDF 98 kb)

Supplementary Note (PDF 74 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morgan, N., Westaway, S., Morton, J. et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 38, 752–754 (2006). https://doi.org/10.1038/ng1826

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng1826

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing